Synthesis and Evaluation of Novologues as C-Terminal Hsp90 Inhibitors with Cytoprotective Activity against Sensory Neuron Glucotoxicity

Citations Over TimeTop 17% of 2012 papers

Abstract

Compound 2 (KU-32) is a first-generation novologue (a novobiocin-based, C-terminal, heat shock protein 90 (Hsp90) inhibitor) that decreases glucose-induced death of primary sensory neurons and reverses numerous clinical indices of diabetic peripheral neuropathy in mice. The current study sought to exploit the C-terminal binding site of Hsp90 to determine whether the optimization of hydrogen bonding and hydrophobic interactions of second-generation novologues could enhance neuroprotective activity. Using a series of substituted phenylboronic acids to replace the coumarin lactone of 2, we identified that electronegative atoms placed at the meta-position of the B-ring exhibit improved cytoprotective activity, which is believed to result from favorable interactions with Lys539 in the Hsp90 C-terminal binding pocket. Consistent with these results, a meta-3-fluorophenyl substituted novologue (13b) exhibited a 14-fold lower ED(50) for protection against glucose-induced toxicity of primary sensory neurons compared to 2.

Related Papers

• → Neuroprotective Properties of Chitosan and Its Derivatives(2010)165 cited
• → Neuroprotective effects of the survival promoting peptide Y-P30(2009)8 cited
• → Combinatorial techniques for enhancing neuroprotection(2010)10 cited
• → Neuroprotection by hypothermia plus alkalinization of dorsal root ganglia neurons through ischemia(2010)9 cited
• POTENTIAL NEUROPROTECTIVE EFFECTS OF HERBAL COMPOUNDS(2015)